Financhill
Back

Adaptimmune Therapeutics PLC Vs. Autolus Therapeutics PLC Industry Stock Comparison

Sell
22

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.98
Seasonality Move:
-24.66%
Sell
46

AUTL
Autolus Therapeutics PLC

Last Price:
3.62
Seasonality Move:
17.32%
Sell
22
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.98. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Autolus Therapeutics PLC (AUTL) is a Sell

Is Autolus Therapeutics PLC a Buy, Sell or Hold?

  • The current Autolus Therapeutics PLC [AUTL] share price is $3.63. The Score for AUTL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • AUTL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.

AUTL Stock Price Chart

What is Autolus Therapeutics PLC's stock price today?

  • The Autolus Therapeutics PLC share price today is $3.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 41.12 Sell
Chaikin Money Flow: 54046 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.99 - 1.21) Sell
Bollinger Bands (100): (0.98 - 1.22) Sell

AUTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 42.85 Sell
Chaikin Money Flow: 457787 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.66 - 4.12) Sell
Bollinger Bands (100): (3.68 - 4.32) Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.97 Buy
20-day SMA: 1.06 Sell
50-day SMA: 1.13 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.98 Sell
20-day EMA: 1.04 Sell
50-day EMA: 1.09 Sell
200-day EMA: 1.09 Sell

AUTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.63 Buy
20-day SMA: 3.88 Sell
50-day SMA: 4 Sell
200-day SMA: 4.88 Sell
8-day EMA: 3.63 Sell
20-day EMA: 3.78 Sell
50-day EMA: 3.93 Sell
200-day EMA: 4.23 Sell

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $0.29 per share, and an increase next year of $0.10 per share.

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Autolus Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):